Status:

COMPLETED

EARLY Assessment of MYOcardial Tissue Characteristics in OBESITY (EARLY-MYO-OBESITY)

Lead Sponsor:

RenJi Hospital

Collaborating Sponsors:

Ningbo Hangzhou Bay Hospital

Shanghai Jiading Central Hospital

Conditions:

Obese

Eligibility:

All Genders

18-75 years

Brief Summary

EARLY-MYO-OBESITY-CMR is a prospective, three-center, cardiac imaging study to investigate cardiac morphology, function, and tissue phenotypes in a cohort of non-diabetic obese adults, and compare wit...

Detailed Description

1. Transthoracic echocardiography was performed to analyze the LV morphology and function. 2. CMR was performed within 24 hours of the echocardiographic examination to assess the cardiac morphology , ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • age 18-75 years without cardiac symptoms or known cardiac diseas;
  • body mass index ≥25 kg/m2
  • Exclusion criteria:
  • coronary artery disease (coronary artery stenosis \>50% on angiography or coronary computed tomography, documented myocardial infarction, or a history of coronary artery bypass graft surgery or percutaneous coronary intervention)
  • non-ischemic cardiovascular disease, such as idiopathic cardiomyopathy, valvular disease, congenital heart disease, or pulmonary heart diseas
  • a left ventricular (LV) ejection fraction of\<50% on echocardiography or a history of heart failure
  • arrhythmia or the presence of bundle branch block on electrocardiography
  • pacemaker or defibrillator implantation
  • renal dysfunction with an estimated glomerular filtration rate of \<60 mL/min/1.73 m2
  • contraindications to cardiac magnetic resonance (CMR) imaging
  • malignancy or life expectancy of less than 2 year
  • inability to provide written informed consent

Exclusion

    Key Trial Info

    Start Date :

    January 1 2019

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 30 2022

    Estimated Enrollment :

    120 Patients enrolled

    Trial Details

    Trial ID

    NCT05277779

    Start Date

    January 1 2019

    End Date

    December 30 2022

    Last Update

    June 1 2023

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Renji Hospital

    Shanghai, Shanghai Municipality, China, 200127